Institutional
First Turn Management, LLC
CIK 0001993440
$895.1M
Reported AUM
33
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · First Turn Management, LLC · Q1 2026
AI · grounded in 13F
First Turn Management, LLC closed its position in GH for a reduction of $27.7M. The fund established several new positions, including ELVN for $24.5M and CELC for $24.0M. Additionally, the fund accumulated shares of UTHR, increasing its position by 64.7%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP DEL | $517.71 | -1.54% | 75.96% | 140.98% | $62.1M | 6.94% | — | HELD |
| 2 | ABVX | ABIVAX SA | $124.92 | 0.47% | 72.81% | 1124.93% | $51.9M | 5.80% | — | HELD |
| 3 | BBIO | BRIDGEBIO PHARMA INC | $80.09 | -2.50% | 68.44% | 59.23% | $51.7M | 5.77% | — | HELD |
| 4 | XENE | XENON PHARMACEUTICALS INC | $62.67 | -2.37% | 110.46% | 263.68% | $45.8M | 5.11% | — | HELD |
| 5 | RVMD | REVOLUTION MEDICINES INC | $187.53 | -2.41% | 424.62% | 560.61% | $45.5M | 5.09% | — | HELD |
| 6 | APGE | APOGEE THERAPEUTICS INC | $134.09 | -0.16% | 255.38% | 484.81% | $43.2M | 4.83% | — | HELD |
| 7 | INSM | INSMED INC | $98.60 | -2.85% | -10.07% | 248.61% | $40.6M | 4.54% | — | HELD |
| 8 | NUVL | NUVALENT INC | — | — | 0.00% | — | $37.9M | 4.24% | — | HELD |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | $105.95 | -5.90% | 108.58% | 567.72% | $37.0M | 4.13% | — | HELD |
| 10 | COGT | COGENT BIOSCIENCES INC | $38.93 | -5.88% | 248.33% | 379.59% | $36.5M | 4.07% | — | HELD |
| 11 | ROIV | ROIVANT SCIENCES LTD | $33.91 | -1.77% | 199.47% | 240.40% | $33.0M | 3.68% | — | HELD |
| 12 | AXSM | AXSOME THERAPEUTICS INC. | $217.99 | -7.10% | 116.13% | 767.06% | $31.9M | 3.56% | — | HELD |
| 13 | IDYA | IDEAYA BIOSCIENCES INC | $35.50 | -2.47% | 49.98% | 54.89% | $29.1M | 3.25% | — | HELD |
| 14 | ORIC | ORIC PHARMACEUTICALS INC | $11.07 | -4.90% | 15.02% | -47.31% | $25.6M | 2.86% | — | HELD |
| 15 | ELVN | ENLIVEN THERAPEUTICS INC | $54.81 | 1.59% | 188.04% | 181.58% | $24.5M | 2.73% | — | HELD |
| 16 | CELC | CELCUITY INC | $86.38 | -1.44% | 119.59% | 298.36% | $24.0M | 2.69% | — | HELD |
| 17 | SRRK | SCHOLAR ROCK HLDG CORP | $47.29 | -3.46% | 34.74% | 23.93% | $21.9M | 2.45% | — | HELD |
| 18 | KYMR | KYMERA THERAPEUTICS INC | $103.40 | -3.37% | 140.11% | 66.00% | $21.2M | 2.37% | — | HELD |
| 19 | CYTK | CYTOKINETICS INC | $77.13 | -4.09% | 112.78% | 136.79% | $18.7M | 2.09% | — | HELD |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | $106.92 | -5.08% | 447.06% | 10.00% | $18.5M | 2.07% | — | HELD |
| 21 | PVLA | PALVELLA THERAPEUTICS INC NE | $139.04 | -7.42% | 291.11% | -66.85% | $18.5M | 2.06% | — | HELD |
| 22 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $27.79 | -2.35% | 33.74% | 194.62% | $17.9M | 2.00% | — | HELD |
| 23 | VRDN | VIRIDIAN THERAPEUTICS INC | $18.92 | -4.92% | 14.30% | 48.73% | $17.8M | 1.99% | — | HELD |
| 24 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $17.5M | 1.95% | — | HELD |
| 25 | FULC | FULCRUM THERAPEUTICS INC | $3.58 | -3.76% | -45.53% | -87.47% | $17.3M | 1.93% | — | HELD |
| 26 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $17.2M | 1.92% | — | HELD |
| 27 | VERA | VERA THERAPEUTICS INC | $32.10 | -2.87% | 54.11% | 119.03% | $17.0M | 1.90% | — | HELD |
| 28 | NTRA | NATERA INC | $267.76 | -0.70% | 100.37% | 127.70% | $16.2M | 1.81% | — | HELD |
| 29 | ERAS | ERASCA INC | $18.15 | -2.84% | 1243.88% | -21.87% | $14.0M | 1.57% | — | HELD |
| 30 | PRAX | PRAXIS PRECISION MEDICINES I | $307.83 | 0.03% | 464.91% | 2.52% | $13.7M | 1.53% | — | HELD |
| 31 | OLMA | OLEMA PHARMACEUTICALS INC | $11.45 | -3.13% | — | — | $11.5M | 1.28% | — | HELD |
| 32 | QURE | UNIQURE NV | $43.63 | 3.41% | — | — | $10.1M | 1.12% | — | HELD |
| 33 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $18.44 | -2.90% | — | — | $5.9M | 0.66% | — | HELD |
Source: SEC EDGAR · accession 0001993440-26-000002. 13F discloses long positions only — shorts, foreign equities, and options are excluded.